Business Context and Reporting Period
Optimumbank Holdings, Inc. filed this Form 8-K on September 19, 2013, reporting events occurring on September 13, 2013. The filing details a material definitive agreement involving the assignment of stock purchase rights between two company directors.
Key Financial Metrics
- Capital Raised: $100,000 in cash proceeds from the sale of common stock.
- Shares Issued: 83,333 shares of common stock ($0.01 par value).
- Price Per Share: $1.20.
- Use of Proceeds: Working capital obligations.
- Remaining Obligation: Director Moishe Gubin's remaining obligation under the original Purchase Agreement was reduced to 1,750,000 shares.
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity beyond the specific transaction proceeds.
Material Changes
On September 13, 2013, Director Moishe Gubin assigned the right to purchase 83,333 shares to Director Joel Klein under a Letter Agreement. Mr. Klein completed the purchase and paid the full $100,000 purchase price to the Company. This transaction was executed under an exemption from registration under Section 4(2) of the Securities Act of 1933.
Outlook, Risks, and Contingencies
Management included a comprehensive list of risk factors associated with forward-looking statements, including:
- Inability to continue as a going concern.
- Inability to raise additional capital on acceptable terms.
- Failure to maintain adequate capital and liquidity levels.
- Regulatory orders and potential supervisory action against the Company or OptimumBank.
- Volatility in credit and equity markets and fluctuations in interest rates.
- Risks associated with the real estate portfolio and Small Business Administration loans.
- Changes in FDIC insurance premiums and regulatory requirements.
Investor Verification Checklist
- Verify the full text of the Letter Agreement (Exhibit 10.1) and the original Stock Purchase Agreement for complete terms.
- Confirm the Company's current liquidity status and ability to meet working capital obligations beyond this $100,000 infusion.
- Review recent regulatory communications or orders affecting OptimumBank's operations.
- Assess the Company's "going concern" status given the explicit risk disclosure.
- Monitor the remaining 1,750,000 shares to be purchased by Mr. Gubin and the likelihood of their completion.